BioClad’s ‘expanding antimicrobial product portfolio’ includes wall cladding, wall and door protection, doors, floors, and ‘the innovative new BioPod’ – a joint-free, pre-plumbed IPS unit, which is easy to install and maintain, and recently won the Queen’s Award for Enterprise 2017 in the International Trade category.
All BioClad products incorporate built-in BioCote antimicrobial protection, which works ‘24/7’, and lasts the product’s lifetime. The silver ion technology reportedly kills up to 99.9% of bacteria, and has proven effective against MRSA, E.Coli, and Influenza.
Recent BioClad installation sites include a £63 million Spire Healthcare hospital, a new 80-bedroom healthcare unit at West London Mental Health Centre, and an £8.1 m expansion of a the neuroscience hospital at the Walton Centre.
Harrogate and District NHS Foundation Trust is the latest NHS Trust to have installed the new BioPod antimicrobial IPS units, during an Accident & Emergency Department refurbishment at Harrogate District Hospital. BioClad said: “With only a two-week lead time and fast installation process, BioPods were specified over competitor products with a six- or eight-week lead times.”
